Janssen Search
Search results
Silvia S. Chen, Ph.D.
SILVIA S. CHEN, PH.D. HEAD OF CHINA LUNG CANCER INITIATIVE AT JOHNSON & JOHNSON AND WORLD WITHOUT DISEASE ACCELERATOR As Head of China for the Lung Cancer Initiative (LCI) at Johnson & Johnson (J&J) and the World Without Disease Accelerator ...
Tina Soares
TINA SOARES GLOBAL HEAD SCIENTIFIC & CLINICAL OPERATIONS THE LUNG CANCER INITIATIVE AT J&J AND WORLD WITHOUT DISEASE ACCELERATOR As Global Head, Scientific & Clinical Operations for the Lung Cancer Initiative (LCI) at Johnson & Johnson (J ...
Rheumatology – Treating Rheumatoid Arthritis
Rheumatology: Leveraging Expertise in Biomarkers and Co-Diagnostics to Personalize Medicine For more than a decade, Janssen has been providing patients and physicians with important therapies to treat rheumatoid arthritis (RA) and other rheumatic diseases ...
Tumor Microenvironment in Oncology
Tumor Microenvironment We focus our efforts on a clearly defined scientific approach. Evolving Tumor Microenvironment Strategy Our evolving strategy centers on innovative approaches to drug development based on a deep understanding of the critical ...
Sustainability – Overview
Helping People Live Longer, Happier, Healthier Lives Sustainability encompasses all of the ways in which we impact the world—by advancing human health and well-being, safeguarding the planet, keeping our business strong and conducting business responsibly ...
Daniel De Schryver
DANIEL DE SCHRYVER PATIENT ENGAGEMENT & ADVOCACY LEAD EUROPE, MIDDLE-EAST AND AFRICA Daniel De Schryver is Patient Engagement & Advocacy Lead for Europe, Middle East and Africa (EMEA). In this function, Daniel is part of a global multi-functional ...
Peter Ronco
PETER RONCO HEAD GLOBAL DEVELOPMENT Peter Ronco is responsible for leading the Global Development organization in delivering the portfolio on time, within budget, and with robust quality while continuously improving to optimize efficiency and the patient ...
Beth Ann Thomas
BETH ANN THOMAS DIRECTOR, BUSINESS OPERATIONS JANSSEN BIOTHERAPEUTICS Beth Ann Thomas is Director of Business Operations for Janssen BioTherapeutics (JBIO), the biotherapeutics engine of Janssen Research & Development. She is responsible for ensuring ...
Natural Language Processing
Today, 80 percent of the world's data is unstructured. Our deep expertise in natural language processing (NLP) empowers our scientists to make use of data and insights extracted from this wealth of data. Natural Language Processing The use and ...
Johan Verbeeck, DVM
JOHAN VERBEECK, DVM VICE PRESIDENT JANSSEN BUSINESS DEVELOPMENT ONCOLOGY Johan Verbeeck, DVM is Vice President, Janssen Business Development, Oncology where he leads business development planning in support of the Oncology Therapeutic Area. His ...